similar unit failures due to the fact neither physicians nor consumers have all of the data required to make adequate judgments of product or service high-quality and authorized tort treatments are sluggish, inefficient, and intensely highly-priced. The adjustments on the CGMP regulation will require manufacturers to increase [Web page 52644] their